IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

NCT05699811 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

BIOLOGICAL: MSC-IFNα
DRUG: Nab paclitaxel
DRUG: Cyclophosphamide
DRUG: Anti-PD-1 monoclonal antibody

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]